(Q48416681)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

1 reference

mild cognitive impairment

1 reference

inferred from title

cognitive dysfunction

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Rafael González-Redondo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

Maria Cruz Rodriguez Oroz

10 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

David Garcia-Garcia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Pedro Clavero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Carmen Gasca Salas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Isabel Lamet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Jose A Obeso

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

8 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

1767-1777

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22872307%20AND%20SRC:MED&resulttype=core&format=json

A systematic review of prevalence studies of dementia in Parkinson's disease

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Defining mild cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Memory and executive function impairment predict dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Metabolic brain networks associated with cognitive function in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Cerebral glucose metabolism in Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Diagnostic criteria for Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Development and validation of a geriatric depression screening scale: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Evaluating storage, retention, and retrieval in disordered memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

A fast diffeomorphic image registration algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Precentral gyrus discrepancy in electronic versions of the Talairach atlas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Automated Talairach Atlas labels for functional brain mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Executive processes in Parkinson's disease: FDG-PET and network analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Collaborative activity between parietal and dorso-lateral prefrontal cortex in dynamic spatial working memory revealed by fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Comparative cytoarchitectonic analysis of the human and the macaque ventrolateral prefrontal cortex and corticocortical connection patterns in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

The interplay between theta and alpha oscillations in the human electroencephalogram reflects the transfer of information between memory systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Changes in cerebral glucose metabolism in patients with Parkinson disease with dementia after cholinesterase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Grey matter atrophy in cognitively impaired Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Assessment of the progression of Parkinson's disease: a metabolic network approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

Changes in network activity with the progression of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2198-5

The central executive: a concept and some misconceptions.

21 January 2018

1 reference

12 December 2020

Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis

1 reference

12 December 2020

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

1 reference

12 December 2020

The interview for deterioration in daily living activities in dementia: agreement between primary and secondary caregivers.

1 reference

12 December 2020

Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space

1 reference

12 December 2020

Validation of postinjection transmission measurements for attenuation correction in neurological FDG-PET studies.

1 reference

12 December 2020

Deterioration of frontal lobe function in normal aging: influences of fluid intelligence versus perceptual speed

1 reference

12 December 2020

Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease.

1 reference

12 December 2020

Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study

1 reference

12 December 2020